Independent Advisor Alliance Vertex Pharmaceuticals Inc Transaction History

Independent Advisor Alliance

$2.71 Billion
Q3 2024

A detailed history of Independent Advisor Alliance transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Independent Advisor Alliance holds 1,174 shares of VRTX stock, worth $544,876. This represents 0.02% of its overall portfolio holdings.

Number of Shares

1,174

Previous 1,813 35.25%

Holding current value

$544,876

Previous $849,000 35.69%

% of portfolio

0.02%

Previous 0.03%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$460.0 - $505.78 $293,940 - $323,193	-639 Reduced 35.25%	1,174 $546,000
Q2 2024 Aug 12, 2024	BUY	$392.81 - $485.53 $168,908 - $208,777	430 Added 31.09%	1,813 $849,000
Q1 2024 May 08, 2024	SELL	$407.69 - $446.08 $11,823 - $12,936	-29 Reduced 2.05%	1,383 $578,000
Q4 2023 Feb 08, 2024	BUY	$343.0 - $410.68 $27,440 - $32,854	80 Added 6.01%	1,412 $574,000
Q3 2023 Oct 24, 2023	SELL	$338.18 - $362.46 $3,381 - $3,624	-10 Reduced 0.75%	1,332 $463,000
Q2 2023 Jul 28, 2023	BUY	$314.42 - $351.91 $43,704 - $48,915	139 Added 11.55%	1,342 $472,000
Q1 2023 May 12, 2023	BUY	$283.23 - $323.1 $340,725 - $388,689	1,203 New	1,203 $379,000
Q3 2022 Nov 04, 2022	SELL	$273.83 - $305.53 $88,994 - $99,297	-325 Reduced 21.38%	1,195 $346,000
Q2 2022 Aug 04, 2022	SELL	$234.96 - $292.55 $90,694 - $112,924	-386 Reduced 20.25%	1,520 $428,000
Q1 2022 May 06, 2022	BUY	$221.42 - $260.97 $422,026 - $497,408	1,906 New	1,906 $497,000
Q3 2021 Nov 01, 2021	SELL	$181.39 - $202.99 $215,309 - $240,949	-1,187 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$187.49 - $221.1 $10,686 - $12,602	57 Added 5.04%	1,187 $239,000
Q1 2021 May 14, 2021	BUY	$207.02 - $241.31 $10,143 - $11,824	49 Added 4.53%	1,130 $243,000
Q4 2020 Feb 11, 2021	SELL	$207.01 - $276.09 $10,350 - $13,804	-50 Reduced 4.42%	1,081 $255,000
Q3 2020 Nov 04, 2020	SELL	$255.65 - $303.1 $2.66 Million - $3.16 Million	-10,424 Reduced 90.21%	1,131 $308,000
Q2 2020 Aug 06, 2020	BUY	$225.48 - $295.8 $2.36 Million - $3.1 Million	10,474 Added 968.92%	11,555 $3.36 Million
Q1 2020 May 14, 2020	BUY	$199.77 - $247.81 $215,951 - $267,882	1,081 New	1,081 $257,000

Others Institutions Holding VRTX

# of Institutions

1,726

Shares Held

222M

Call Options Held

1.58M

Put Options Held

1.36M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $119B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Independent Advisor Alliance, based on Form 13F filings with the SEC.

News

Stay updated on Independent Advisor Alliance with notifications on news.

Account

Independent Advisor Alliance Vertex Pharmaceuticals Inc Transaction History